Services

Safety-led explainers

Our guides organize the questions that can get lost when ibogaine is discussed as a shortcut: psychiatric history, medication interactions, cardiac concerns, monitoring, and the limits of evidence. The main safety overview keeps the central question in view—what is known, what is uncertain, and why bipolar disorder can change the risk discussion.

For context on the substance itself, the basic description of ibogaine is useful, while our purpose is narrower: translating broad claims into careful questions a person or family can take seriously.

Decision frameworks, not directives

These materials help readers distinguish information from medical advice. They frame the issues that deserve careful consideration before acting, including the reported duration questions covered in how long ibogaine effects may last and the importance of an individual history of mood episodes, medications, and heart-related risks.

The U.S. Food and Drug Administration notes that ibogaine-containing products carry serious risks. That does not resolve every personal question, but it makes a safety-first approach more appropriate than confident predictions.

Research summaries in plain language

We summarize evidence without treating early findings, personal stories, or marketing language as settled conclusions. Readers can begin with our account of how Long Waypoint 72 approaches its work: careful sourcing, plain language, and respect for uncertainty.

Topics that circulate through unrelated communities can also need different scrutiny. Questions raised around ibogaine and football are not interchangeable with questions about bipolar disorder, medication changes, or psychiatric vulnerability.

Frequently asked safety questions